rTMS and Bipolar Depression: Predicting Clinical Response

Article

Neuroimaging could help predict clinical response to treatment in bipolar depression.

Kari/Adobestock

Kari/Adobestock

A recent systematic review collected evidence on neuroimaging findings and biomarkers related to response to repetitive transcranial magnetic stimulation (rTMS) in patients with bipolar depression.1

Research indicates that alternative treatments like neurostimulation techniques, such as rTMS, have had positive results in treating unipolar depression. Thus, neurostimulation has been also proposed as a treatment option for bipolar disorder.2-5 Researchers have particularly focused on neural correlates of response to rTMS using different neuroimaging techniques, such as functional, structural, and metabolic imaging.

“rTMS has become a promising and effective strategy for managing BD, due to its safety profile, non-invasive nature, and improved focality, with response rates of approximately 40% to 50%,” said Shamabadi et al.1

The systematic review found 5 main neuroimaging correlates of rTMS response:

1. Right insula activation

2. Changes in the activity of prefrontal and subcortical circuits in concert with ventromedial prefrontal deactivation

3. Increase in dmPFC-thalamus connectivity

4. Decrease in the connectivity of sgACC-caudate, dmPFC-insula, sgACC-midcingulate cortex, and dmPFC and parahippocampal gyrus/amygdala

5. Reduced SN connectivity

The systematic review results indicated that neuroimaging methods with TMS had the ability to predict clinical response to treatment and could provide insights into the underlying biological mechanisms of BD. Researchers could determine which patients are likely to have positive treatment response by observing brain activity and structural changes both before and after TMS treatment. Clinicians could then tailor treatment to the individual patient based on assessment of efficacy.

“This personalized approach to treatment can lead to improved patient outcomes, reduced health care costs, and increased patient satisfaction,” Shamabadi et al reported.1

How has TMS helped your patients? Share your thoughts with us via PTEditor@mmhgroup.com.

References

1. Shamabadi A, Karimi H, Cattarinussi G, et al. Neuroimaging correlates of treatment response to transcranial magnetic stimulation in bipolar depression: a systematic review.Brain Sci. 2023;13(5):801.

2. McGirr A, Karmani S, Arsappa R, et al. Clinical efficacy and safety of repetitive transcranial magnetic stimulation in acute bipolar depression.World Psychiatry. 2016;15(1):85-86.

3. Lipsman N, McIntyre RS, Giacobbe P, et al. Neurosurgical treatment of bipolar depression: Defining treatment resistance and identifying surgical targets.Bipolar Disord. 2010;12(7):691-701.

4. Holtzheimer PE, Kelley ME, Gross RE, et al. Subcallosal cingulate deep brain stimulation for treatment-resistant unipolar and bipolar depression.Arch Gen Psychiatry. 2012;69(2):150-158.

5. Bahji A, Hawken E, Sepehry A, et al. ECT beyond unipolar major depression: systematic review and meta-analysis of electroconvulsive therapy in bipolar depression.Acta Psychiatr Scand. 2019;139(3):214-226.

Related Videos
journey
© 2024 MJH Life Sciences

All rights reserved.